[TGA] the 2024 compounding rule change closed a whole access route overnight
the 2024 compounding rule change closed a whole access route overnight. It is the sort of thing everyone half-believes and nobody writes down.
The national shortage database is a primary source with expected resolution dates attached. It is public, searchable, and consistently more accurate than reporting about it.
Australia and New Zealand have different regulators, different funding bodies and different arrangements. An answer for one is not evidence about the other.
Compounded supply arrangements have changed materially in recent years. Advice predating that change describes a situation that no longer applies.
Sceptical readings welcome. The confident ones are the ones I distrust.
best — the order this archive was captured in
Personal importation provisions exist, are narrow, and carry conditions. Any summary of them here should be checked against the current official wording rather than a forum post.
Where to look instead of asking, which will nearly always be faster.
The national shortage database is public, searchable and carries expected resolution dates. The subsidy criteria for each indication are published. Your pharmacist can check wholesaler availability in a few minutes, which is a different question from what is on the shelf.
Between those three, most questions on this board are answerable in half an hour with primary sources. The board is genuinely useful for experience, pricing comparison and the parts that are not written down anywhere — it is a poor substitute for a document that exists.
the Medsafe position in New Zealand is its own thing entirely
That figure is a private price at one pharmacy, not a national one.
Same. Private pricing varies here as much as anywhere and people assume it is fixed.
Have you checked the shortage database directly?
compounded supply arrangements changed and the threads have not caught up
Correction: that is the registration decision, not the subsidy listing. They are made by different bodies.
Assumed the New Zealand position applied here. It does not, and someone corrected me politely with the actual source.
Checked the shortage database myself instead of reading the coverage. Expected resolution date was right there and the panic thread was wrong.
Subsidy criteria and authority requirements are published. For eligibility questions those documents are authoritative and this board is not.
PBS listing and TGA registration are two different questions
the price you pay depends on the listing status of your indication
private script pricing varies by pharmacy here too
The two decisions that this whole board turns on, kept apart.
Registration means a product may lawfully be supplied. Subsidy listing means the public system will fund it, for a defined indication, against published criteria. They are made by different bodies on different timetables, and a product can be registered and unsubsidised for a given use for a long time.
Almost every "why can I not get this" thread here is really a question about the second decision being answered with facts about the first. Say which one you are asking about and the thread resolves in two replies.
The two decisions that this whole board turns on, kept apart.
Disagreeing with this bit: that advice predates the change in compounded arrangements.
Asked the pharmacist to check the wholesaler and had a definite answer in about four minutes.
What did the pharmacy quote for the private price?
Push back: the compounded arrangements changed and the advice you are quoting predates the change.